TP73 and non-small cell lung carcinoma: We also evaluated differences in circulating levels of TP73‐AS1 and CRNDE based on the TNM stage of NSCLC by comparing circulating levels of the two lncRNAs in patients with stage I, stage II, and stage IIIA NSCLC and healthy control groups in the training and testing sets combined.